Here's Jim Cramer's Tips for Navigating the Markets During the Iran Conflict
Jim Cramer's advice to investors dealing with the fallout from the US-Israeli attack on Iran: be selective. With stocks initially…
health care industry
Why Novo Nordisk's expansion in Ireland is key to fighting Eli Lilly
Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its production capabilities to…
We are adding stock to our Bullpen; resilient to recessions and AI disruption
We added a new Bullpen name during Friday's monthly meeting, and it has minimal economic sensitivity and faces little to…
Life Time and Planet Fitness results show K-shaped economy
Two of the largest U.S. gym operators posted the same headline in their latest earnings reports: strong growth. But beneath…
Trump angers MAHA with glyphosate order and gives Democrats a chance
An attendee holds a Make America Healthy Again (MAHA) Moms sign at the end of a press conference announcing the…
Novartis and Genentech sue for illegal importation of prescription drugs
A sign for Swiss pharmaceutical giant Novartis is seen atop a building in Basel, Switzerland, on September 9, 2025. Fabrice…
What's next for Novo Nordisk's anti-obesity drug CagriSema?
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Novo Nordisk to cut US list prices for Wegovy and Ozempic by up to 50%
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, on February…
Eli Lilly launches anti-obesity drug Zepbound with one-month dosage
An Eli Lilly & Co. Zepbound injection pen placed in the Brooklyn borough of New York on March 28, 2024.…
Novo Nordisk Shares Fall as Weight Loss Drug Fails to Beat Eli Lilly
The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, November 5, 2025. Nichlas Pollier | Bloomberg | fake images…